Efficacy News and Research

RSS
Prescribing generic heart medications in Medicare Part D could result in substantial savings

Prescribing generic heart medications in Medicare Part D could result in substantial savings

Biologic agent dupilumab effective in improving asthma exacerbations and lung function, study shows

Biologic agent dupilumab effective in improving asthma exacerbations and lung function, study shows

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Effect of SARS-CoV-2 variant emergence on efficacy of neutralizing antibodies and vaccines

Immune responses against SARS-CoV-2 Delta variant after BNT162b2 vaccination in people living with HIV

Immune responses against SARS-CoV-2 Delta variant after BNT162b2 vaccination in people living with HIV

Immunogenicity and safety of COVID-19 subunit vaccine Nanocovax in animal models

Immunogenicity and safety of COVID-19 subunit vaccine Nanocovax in animal models

Yokogawa Develops Single Cellome System SS2000 for Subcellular Sampling

Yokogawa Develops Single Cellome System SS2000 for Subcellular Sampling

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Positive results from Phase 3 study of Medicago’s plant-based COVID-19 vaccine candidate announced

Study shows how senescent cells can be an underlying cause of kidney damage

Study shows how senescent cells can be an underlying cause of kidney damage

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

The antiviral potential of 4′-fluorouridine as an oral treatment against RSV and SARS-CoV-2

An assessment of pH-sensitive cationic lipid nanoparticles for drug delivery

An assessment of pH-sensitive cationic lipid nanoparticles for drug delivery

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

Cas12a-based bio-sensor for detecting SARS-CoV-2 mutations

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Antibody response to COVID-19 vaccine may be affected by the body’s circadian rhythms

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

Octapharma USA announces FDA approval of cutaquig 16.5% for pediatric PI patients

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

New approach to enhance the therapeutic efficacy of liver cancer immunotherapy

Combination of prior infection and vaccination produces a more potent defense against SARS-CoV-2

Combination of prior infection and vaccination produces a more potent defense against SARS-CoV-2

Impact of infection control measures and vaccines in protecting healthcare workers from COVID-19

Impact of infection control measures and vaccines in protecting healthcare workers from COVID-19

‘Moving molecule’ therapy for severe spinal cord injury

‘Moving molecule’ therapy for severe spinal cord injury

Exploring SARS-CoV-2 vaccine responsiveness in immunosuppressed patients

Exploring SARS-CoV-2 vaccine responsiveness in immunosuppressed patients

Immune response of Pfizer vaccinees who received Moderna or Pfizer booster

Immune response of Pfizer vaccinees who received Moderna or Pfizer booster

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.